Announcements Trials
Browse Landscape

Phase

Phase 1/2 4Phase 2 3Phase 3 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 35Other hematologic neoplasm 25Sarcoma 9Myeloid 8CNS 6Breast 3Other solid neoplasm 2Other neoplasm 2Genitourinary 2Thoracic 1Plasma cell 1Gynecologic 1Gastrointestinal 1Dermatologic 1Classical hematology 1

Conditions

Breast Neoplasms 3Lymphoma, Non-Hodgkin 1Inflammatory Breast Neoplasms 1Chemotherapy-Related Cognitive Impairment 1

Interventions

Trastuzumab 349Paclitaxel 310Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 215Letrozole 185Fulvestrant 178Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 114pembrolizumab 113Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 66Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Mesna × Breast × Clear all
NCT00003042 2026-02-20

Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer

City of Hope Medical Center

Phase 2 Completed
41 enrolled 9 charts
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01205503 2016-02-24

Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release

University of Kentucky

Phase 2 Completed
32 enrolled 24 charts
BreastLymphoid

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Lymphoma, Non-Hodgkin

NCT00006260 2010-06-11

Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer

Case Comprehensive Cancer Center

Phase 2 Completed
36 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡